JW: The particular point in Sasha’s case is clearly around Drug 1 prescribing and having a consistency in communication around decisions made in MH team in relation to risk and ensure all those involved in prescribing are aware of those risks.

JW: The particular point in Sasha’s case is clearly around Drug 1 prescribing and having a consistency in communication around decisions made in MH team in relation to risk and ensure all those involved in prescribing are aware of those risks.